US Patent Issued to Helsinn Healthcare on July 28 for "Liquid oral formulations of netupitant and palonosetron" (Italian, Swiss Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,060, issued on July 28, was assigned to Helsinn Healthcare SA (Lugano, Switzerland).

"Liquid oral formulations of netupitant and palonosetron" was invented by Davide Parisi (Como, Italy), Stefano Frizzarin (Varese, Italy) and Flavio Fabiani (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Orally administered liquid formulations of netupitant and palonosetron, and suitable pharmaceutical excipients, in a solvent system that allows for the netupitant to be suspended and the palonosetron to be dissolved, that are efficacious, chemically stable and physiologically balanced for safety and efficacy."

The patent was filed on Sept. 24, 20...